Many faculty members had known someone with Lyme disease or PTLDS, but few had been diagnosed themselves. Most believe that PTLDS can be severe and chronic, is not easy to treat, and does not resolve on its own, but were uncertain about its aetiology. Most respondents also felt that the...
CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study. Clin Vaccine Immunol. 2016; 23(9):757-66... JN Aucott,MJ Soloski,AW ...
Post-treatment Lyme disease syndrome (PTLDS) is used to describe Lyme disease patients who have the infection cleared by antibiotic but then experienced persisting symptoms of pain, fatigue, or cognitive impairment. Currently, little is known about the cause or epidemiology of PTLDS. We conducted ...
“Subjects were regarded as having Post-Treatment Lyme Disease Syndrome (PTLDS) if the symptoms developed at the time of presentation (or were intensified over the subject’s pre-Lyme disease symptoms), or within 6 months of diagnosis,” and lasted for 6 months or more following completion of...
In a study using specialized imaging techniques, Johns Hopkins Medicine researchers report distinctive changes in the "white matter" and other brain tissue physiology of those with post-treatment Lyme disease, a condition affecting 10% to 20% of the near
Twelve out of 28 children with Lyme disease evaluated at an academic medical center in the Netherlands remained ill with post-treatment Lyme borreliosis syndrome (PTLBS). These 12 children presented with various complaints, including fatigue, general malaise and pain. There were no other medical exp...
We present a precision medical perspective to assist in the definition, diagnosis, and management of Post Treatment Lyme Disease Syndrome (PTLDS)/chronic Lyme disease. PTLDS represents a small subset of patients treated for an erythema migrans (EM) rash with persistent or recurrent symptoms and fu...
The present study evaluated the C6 test as a predictor of therapy outcome in a population of patients with post-treatment Lyme disease syndrome. The serum specimens tested were from patients with well-documented, previously treated Lyme borreliosis who had persistent musculoskeletal or neurocognitive ...
Purpose:Post-treatment Lyme disease (PTLD) is characterized by patient-reported symptoms after treatment for Borrelia burgdorferi infection. The primary aim of this study was to assess whether participants with a history of Lyme disease (LD) would be more likely to meet criteria for PTLD than ...
Post-treatment Lyme disease syndrome symptomatology and impact on life functioning: is there something here? Qual Life Res 2013;22:75-84.Aucott, J.N.; Rebman, A.W.; Crowder, L.A.; Kortte, K.B. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: Is ...